Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by slaveonfoolson Jul 02, 2013 8:30pm
13 Views
Post# 21585448

RE:thanks Pennystocks for nothing

RE:thanks Pennystocks for nothingI go out for the afternoon and I missed the NR..good stuff definitely starting to snowball here.

Hobby, I posted a write-up yesterday on Sirona that sums up where we are at quite nicely. The company has multiple companies pursuing their skin lightener and Ive heard at least one wants exclusive rights to 1 of the 2 compunds...Both compounds are superior to the current market leader...and safer.

SGLT2 may take some time but Ive heard that both big deals should be done by yrs end (and thats being very conservative). Our SGLT2 has been tested on rats and is 7x more effective that J&Js SGLT2 that just got FDA approval in March.

Neil Belienke has come aboard and simplified Sirona's structure to focus on only a few projects at once and get them through pre-clinical where they can then pursue a partner with deep pockets to take the product the rest of the way to market.

Dr.G has something like 17million escrowed shares so she is very motivated for success and if I remember correctly she said in an interview not too long ago that she hopes/thinks a deal will be be completed on one of the skin compunds by years end...
Bullboard Posts